Clemens Guenther PhD

Dr. Clemens Gunther received his diploma in biology and doctorate for natural sciences from the Free University, Germany. he started his professional career at Schering AG, Germany, as a scientist specializing in the development of Transdermal Therapeutic Systems and topical Dermatologicals. he became Head of Animal Pharmacokinetics within the Function of Pharmacokinetics. Clemens Günther was Director and Head of Global Preclinical Development at Intendis GmbH, branded later on as Bayer Dermatology. In this position, he was responsible for Nonclinical Safety for the marketed product portfolio of Bayer Dermatology as well as the global preclinical development strategy, including human DMPK for development and life cycle management projects at Intendis GmbH.

After the integration of the Intendis R&D platform into the Bayer Pharma R&D structure in July 2013, Clemens Günther took over his present role as Director of Nonclinical Safety Consumer Health within the Division of Bayer Pharmaceuticals. In this actual position, he is still involved in the development of new chemical entities, including small molecules and biologicals, as well as the life cycle management of marketed, prescribed, and OTC drug products.